Skip to main content
CDC Website

Health Care Planning

Expanding Access to Hepatitis C Prevention, Testing, and Treatment in Prisons

This packet of recommendations discusses how in October 2022, INHSU Prisons and the Coalition for Global Hepatitis Elimination (CGHE), Task Force for Global Health convened a workshop on the strategies for expanding access to hepatitis C virus (HCV) prevention, testing, and treatment in prison settings. During the workshop, barriers and recommendations to accelerating HCV elimination in prison settings were examined in four areas: 1) Policy, 2) Implementation, 3) Financing, and 4) Awareness.

TelePrEP Online Learning Series

This TelePrEP Online Learning Series provides information and resources to health departments, community-based organizations, and community health centers wanting to expand, strengthen, or develop a telePrEP program. 

Innovation Health Practices

The United States Agency for International Development (USAID) is issuing this Broad Agency Announcement (BAA) to seek participants to co-create, co-design, co-invest, and collaborate on creating, piloting, and scaling innovative research and development interventions utilizing innovative health practices to help reduce disease and mortality rates worldwide.

Formative and Pilot Intervention Research to Optimize HIV Prevention and Care Continuum Outcomes (R34 Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) encourages formative research, intervention development, and pilot-testing of interventions. Primary scientific areas of focus include the feasibility, tolerability, acceptability and safety of novel or adapted interventions that target HIV prevention or treatment.

Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R21 Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) solicits innovative research to optimize HIV prevention and care which is aligned with NIMH Division of AIDS Research (DAR) priorities. Applications may include formative basic behavioral and social science to better understand a step or steps in the HIV prevention or care continuum, and/or the initial development and pilot testing of innovative intervention approaches. Applicants are encouraged to read current Notices of Special Interests (NOSIs) from NIMH DAR for further information about the Divisions research priorities.

NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)

This Funding Opportunity Announcement (FOA), issued by the National Institute of Allergy and Infectious Diseases (NIAID), invites applications for investigator-initiated Resource-Related Research Projects (R24). The proposed resource must provide a significant benefit to currently funded high priority projects in need of further coordination and support in the areas specified. Under rare circumstances, this mechanism may be used to support development of a new resource to the broader scientific community of the NIAID.

BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research

The USAMRDC’s mission is to provide solutions to medical problems of importance to the American Service Member at home and abroad, as well as to the general public at large. The scope of this effort and the priorities attached to specific projects are influenced by changes in military and civilian medical science and technology (S&T), operational requirements, military threat assessments, and national defense strategies. Extramural research and development programs play a vital role in the fulfillment of the objectives established by the USAMRDC.

National HIV/AIDS Strategy for the United States: Updated to 2020

This report is an updated Strategy that looks ahead to 2020 and spells out the U.S. goals and objectives for the prevention and elimination of HIV infection. The Strategy has four main goals: 1) reducing new HIV infections; 2) increasing access to care and improving health health outcomes for people living with HIV; 3) reducing HIV-related health disparities and health inequities; and 4) achieving a more coordinated national response to the HIV epidemic.